Arcitumomab

From WikiMD.org
Jump to navigation Jump to search

Arcitumomab

Arcitumomab (pronounced: ar-si-tu-mo-mab) is a monoclonal antibody used in the detection of certain types of cancer. It is a radiopharmaceutical agent that is used in immunoscintigraphy procedures.

Etymology

The name "Arcitumomab" is derived from the Latin "arcere" meaning to ward off, and "tumomab" is a common suffix for monoclonal antibodies.

Usage

Arcitumomab is used in the detection of colorectal cancer. It is administered intravenously and works by binding to a specific antigen, carcinoembryonic antigen (CEA), which is often present in high amounts in individuals with colorectal cancer.

Related Terms

  • Monoclonal antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
  • Radiopharmaceutical: A drug that contains radioactive substances which are used to treat certain conditions or to image certain parts of the body.
  • Immunoscintigraphy: A type of imaging test that uses radioactive substances to detect certain diseases in the body.
  • Carcinoembryonic antigen (CEA): A protein that may be higher in individuals with certain types of cancers, including colorectal cancer.

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski